Literature DB >> 12114817

p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues.

Lori A. Erickson.   

Abstract

Endocrine tumors are often diagnostic challenges. Recent studies have suggested that proteins that regulate cell cycle may have diagnostic and prognostic utility in endocrine tumors. p27(kip1) (p27) is a cyclin-dependent kinase inhibitor that regulates the transition from the G1 to the S phase of the cell cycle. p27 and other cell-cycle proteins are becoming increasingly important in assessing the biologic behavior of endocrine neoplasms, classifying hyperplastic and neoplastic endocrine tissues, and in the progression of endocrine tumors. p27 appears to separate normal from neoplastic endocrine tissues and, in some cases, benign from malignant endocrine tumors. However, there is overlap in p27 expression among individual cases of benign and malignant tumors, and p27 has only limited prognostic utility in endocrine tumors compared to some epithelial tumors such as breast and prostate neoplasms. Thus, more effective molecular and cellular markers that can be used for diagnostic and prognostic purposes in endocrine pathology are needed.

Entities:  

Year:  2000        PMID: 12114817     DOI: 10.1385/ep:11:2:109

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  87 in total

1.  Frequent loss of the P16INK4a gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

2.  Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

Authors:  Y Katayose; M Kim; A N Rakkar; Z Li; K H Cowan; P Seth
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

3.  Genetic abnormalities in sporadic parathyroid adenomas.

Authors:  E Friedman; A E Bale; S J Marx; J A Norton; A Arnold; T Tu; G D Aurbach; A M Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

4.  Expression of p27kip1 in prostatic adenocarcinoma.

Authors:  J C Cheville; R V Lloyd; T J Sebo; L Cheng; L Erickson; D G Bostwick; C M Lohse; P Wollan
Journal:  Mod Pathol       Date:  1998-04       Impact factor: 7.842

5.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.

Authors:  E D Hsi; L R Zukerberg; W I Yang; A Arnold
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

6.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

7.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.

Authors:  H Nakazumi; H Sasano; K Iino; Y Ohashi; S Orikasa
Journal:  Mod Pathol       Date:  1998-12       Impact factor: 7.842

9.  Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.

Authors:  S Takeuchi; H P Koeffler; D R Hinton; I Miyoshi; S Melmed; I Shimon
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

10.  TGFB, TGFB Receptors, Ki-67, and p27(Kip)l Expression in Papillary Thyroid Carcinomas.

Authors:  Ricardo V. Lloyd; Jorge A. Ferreiro; Long Jin; Tom J. Sebo
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more
  4 in total

Review 1.  Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate.

Authors:  R V Lloyd
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Molecular pathology of pituitary adenomas.

Authors:  R V Lloyd
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

3.  Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradation.

Authors:  Ricardo V Lloyd; Katharina H Ruebel; Shuya Zhang; Long Jin
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 4.  Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice.

Authors:  C Christofer Juhlin; Lori A Erickson
Journal:  Endocr Pathol       Date:  2020-12-02       Impact factor: 3.943

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.